Actuate Therapeutics, Inc. (ACTU) Cash flow

36 Followers

Actuate Therapeutics, Inc. Cash Flow

ACTU's free cash flow for Q4 2025 was $-3.74M. For the 2025 fiscal year, ACTU's free cash flow was decreased by $2.64M and operating cash flow was $-3.74M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22
Operating Cash Flow	$ -19.21M	$ -21.84M	$ -21.63M	$ -17.79M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 23.72M	$ 27.53M	$ 4.13M	$ 19.26M
End Cash Position	$ 13.16M	$ 8.64M	$ 2.96M	$ 20.45M
Free Cash Flow	$ -19.21M	$ -21.84M	$ -21.63M	$ -17.79M

Currency in USD